Close



May 17, 2023 06:07AM
May 16, 2023 11:13AM
Dec 1, 2022 11:06AM
Oct 6, 2021 04:18PM
Sep 30, 2021 08:35AM
Jun 21, 2021 08:13AM
Jun 4, 2021 08:36AM Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference
May 24, 2021 08:00AM
Mar 19, 2021 08:33AM
Feb 17, 2021 09:23AM
Nov 12, 2020 08:00AM
Nov 3, 2020 08:05AM
May 19, 2020 08:00AM
May 8, 2020 06:22AM Horizon Therapeutics (HZNP) PT Raised to $55 at Jefferies on Increased Tepezza Uptake
Apr 28, 2020 08:34AM
Nov 13, 2019 04:15PM
Mar 5, 2019 09:24AM
Feb 28, 2019 12:45PM
Oct 25, 2018 08:00AM
Jan 2, 2018 05:35PM
Nov 7, 2017 08:34AM Horizon Pharma (HZNP) PT Raised to $21 at Jefferies; Reiterates Buy
Nov 2, 2017 04:05PM
Oct 5, 2017 06:59AM
Sep 27, 2017 09:17AM
May 26, 2017 07:00AM
May 9, 2017 07:31AM
Dec 16, 2016 07:37AM
Dec 16, 2016 07:27AM An Important Win for Horizon Pharma (HZNP) - Jefferies
Nov 9, 2016 12:03PM
Nov 4, 2016 07:00AM
Sep 12, 2016 09:41AM
Sep 12, 2016 07:01AM
Sep 12, 2016 07:00AM
Jun 2, 2016 07:00AM
Mar 2, 2016 08:58AM Horizon Pharma (HZNP) Raises Prices on Several Products - Jefferies
Jan 19, 2016 10:49AM
Jan 19, 2016 09:33AM
Jan 19, 2016 09:07AM
Dec 11, 2015 09:48AM
Dec 11, 2015 07:01AM
Dec 11, 2015 07:00AM
Nov 23, 2015 10:37AM Notable Analyst Rating Changes 11/23: (CMG) (JRVR) (PBF) Upgraded; (TXTR) (CTCT) (CAVM) Downgraded
Nov 23, 2015 07:39AM
Nov 4, 2015 07:00AM
Jul 21, 2015 09:28AM
Jul 13, 2015 12:52PM
Jul 13, 2015 12:50PM
Jul 7, 2015 07:01AM
Jul 7, 2015 07:00AM Horizon Pharma plc Proposes to Acquire Depomed, Inc. for $29.25 per Share in an All-Stock Transaction, Representing a 42 Percent Premium to Depomed's Shareholders
May 21, 2015 10:45AM

56,504 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All